Clinical studies recruiting near Wheaton

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in
Phase 3 · Study Site · Pharvaris Netherlands B.V. · NCT06679881 The Grief Navigation Trial: A Comparison of Two Interventions to Support Parents After Their Child's Unexpected or Traum
NA · DuPage County Coroner's Office · Ann & Robert H Lurie Children's Hospital of Chicago · NCT06136260 An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Phase N/A · Institute for Allergy and Asthma · Blueprint Medicines Corporation · NCT07264959 A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneou
Phase 3 · Accellacare Duly Health and Care · Novartis Pharmaceuticals · NCT06868212 Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
Phase 1/Phase 2 · Institute For Asthma & Allergy · Institute for Asthma and Allergy · NCT07046806 A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Stu
Phase 2 · Atd002 52018 · UCB Biopharma SRL · NCT07277660 Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bl
Phase N/A · UroPartners, LLC · Convergent Genomics, Inc. · NCT07673016 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT07428499

Look up another city

Look up another condition